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Patient profi le of a tertiary 
obstetric-cardiac clinic
MANAGEMENT OF 
CARDIAC DISEASE 
IN PREGNANCY
relatively fixed combination of factors, can often surprise one. 
Gestational age at presentation, the unique combination of 
maternal functional status at a given gestation coupled with 
the severity of cardiac disease and the known natural course 
ABSTRACT
Background: Cardiac disease is the most important medi-
cal cause of maternal mortality in South Africa. Mana-
gement of women with cardiac disease in pregnancy is 
highly specialised and they should ideally be evaluated 
early in pregnancy and in a multidisciplinary fashion with 
the aim of formulating a perinatal management plan. In 
order to facilitate the effi cient management of these 
patients in the context of a large tertiary hospital in 
South Africa a combined obstetric-cardiac (O-C) clinic 
was established at Tygerberg Academic Hospital (TBH) 
in 2010.
Objective: The purpose of this review is to describe the 
patient profi le of an obstetric-cardiac clinic in South 
Africa, specifi cally the TBH O-C clinic and to share the 
lessons learnt from establishing this clinic.
Methods: Retrospective review performed at TBH, a 
referral centre in the Western Cape Province of South 
Africa. All women evaluated and/or managed at the 
Obstetric-Cardiac clinic between 10 August 2010 and 
4 December 2012 were included. 
Results: There were 231 women, rheumatic heart disease 
(n=79; 34.2%) was the predominant cardiac disease 
followed by congenital heart disease (n=78; 33.8%), medical 
conditions (n=38; 16.4%) and previous peripartum cardio-
myopathy (n=9; 3.9%). Eighty-two women (35.5%) were 
perceived to be extremely high risk and their entire 
pregnancies were managed in the Obstetric-Cardiac 
clinic. The most common RHD lesion was mitral regur-
gitation (34.2%) and mixed mitral valve disease (24.1%). 
The most frequent CHD was ventricular septal defects 
(n=27; 35%).
Conclusions: The cardiac disease profi le of patients seen 
at this obstetric-cardiac clinic in a South African tertiary 
hospital refl ects a transition from the disease profi le of 
a typical developing country (high burden of rheumatic 
heart disease) to the disease profi le seen in a more devel-
oped country (high burden of congenital heart disease). 
This could indicate improved quality of socio-economic 
development and the health care system. The increasing 
complexity of cardiac pathology that has to be dealt 
with in pregnant patients presenting to a tertiary hospital 
requires close collaboration between the obstetrician, 
cardiologist, cardiac surgeon and anesthetist caring for 
these patients. A dedicated obstetric-cardiac clinic is a 
good model to utilise in a tertiary hospital when aiming to 
optimise the care of patients with cardiac disease in 
pregnancy.  SAHeart 2014;11:80-85
INTRODUCTION
Normal pregnancy is characterised by significant maternal car-
diovascular adaptation that aims to ensure adequate utero-
placental blood flow for sustainable fetal development. This 
physiological cardiovascular adaptation also allows the pregnant 
mother to cope with the increased metabolic demands insti-
tuted by the pregnancy state. However, underlying cardiac 
conditions affect 0.2-3% of all pregnancies.(1-3) Limited cardio-
vascular reserve coupled with these, often substantial, haemo-
dynamic changes place a subset of these women at risk of 
decompensation during pregnancy. This is associated with sig-
nificant cardiovascular and obstetric complications and drives 
poor outcomes in high risk groups.(3,4) Maternal cardiac disease 
in pregnancy is not infrequently complicated by heart failure, 
arrhythmias and stroke while these babies are at increased 
risk of low birth weight, prematurity and death.(5-7) It is there-
fore not surprising to find that maternal cardiac disease is the 
leading cause of maternal mortality in many first world coun-
tries.(8) In South Africa “medical conditions” as a group is ranked 
fifth in terms of causes of maternal mortality and cardiovas-
cular disease is foremost amongst the medical conditions in 
this group by some margin. Cardiac failure and ventricular dys-
function are important presenting problems amongst recorded 
mortalities from cardiac disease.(9)
The individuality and uniqueness of each pregnancy complicates 
decision making and guideline setting significantly. The com-
plexity that arises from what superficially appears to be a 
J.L. van der Merwe*, D.R. Hall*, P. Herbst# and A. Doubell#
* Department of Obstetrics and Gynaecology, University of 
Stellenbosch and Tygerberg Academic Hospital, South Africa
# Division of Cardiology, Faculty of Medicine and Health Sciences, 
University of Stellenbosch and Tygerberg Academic Hospital, 
South Africa
Address for correspondence: 
Dr J.L. van der Merwe
Department of Obstetrics and Gynaecology
University of Stellenbosch and Tygerberg Academic Hospital
PO Box 19081
Tygerberg
7505
South Africa
  
Email: 
hvdm@sun.ac.za
81
A
ut
um
n 
20
14
Vo
lu
m
e 
11
 •
 N
um
be
r 2
of the disease in pregnancy, maternal comorbidities, fetal 
health and perceived viability in the era of modern neonatal 
care and a mother’s wishes to carry to term a precious baby or 
her consideration for a young family at home are just a few 
factors that conspire to make each case unique. In addition, 
decision-making requires a sound knowledge of the available 
therapeutic strategies, the risks inherent in each for mother and 
child and the timing of such a strategy that will limit risk as far 
as possible. The age-old mantra of mother first must there-
fore in each case be weighed against what is the perceived 
true risk for mother and fetus and a management strategy 
decided on that will lead to the best fetal outcome without 
compromising maternal outcome. In order to achieve this, a 
multi disciplinary approach needs to be followed.
Healthy pregnant women without underlying cardiac disease 
who present with symptoms mimicking cardiac disease repre-
sent another challenging group to evaluate. Fatigue, dyspnoea 
and even syncope are found in healthy pregnant women and if 
associated with physical, ECG or echocardiographic findings 
that simulate cardiovascular pathology in their own right, may 
complicate the evaluation of the pregnant mother. Differen-
tiating normal from abnormal within a screening context as 
well as the management of patients with established cardiac 
disease in pregnancy are challenges that warrant a specialised 
solution. The risk stratification strategy chosen to address these 
complexities should also be comprehensive and evidence 
based as far as possible.
The need for a specialised combined Obstetric-Cardiac 
Clinic (O-C clinic) at our own institution (Tygerberg Hospital) 
had became more and more evident in the last decade. The 
requirement for cardiovascular evaluation of the pregnant 
patient with known or suspected cardiac disease (as well as 
those planning pregnancy) had become a large service com-
ponent in an already overburdened general cardiology clinic. 
Waiting times for the referral of pregnant patients where 
decision-making often requires an expedited evaluation neces-
sarily makes elective clinic planning difficult. Furthermore, the 
combined service burden to both obstetrics and cardiology 
was clearly greater because of the typical evaluate – refer – 
reassess cycle that was initiated between the services. Patient 
counselling pre-pregnancy and during pregnancy often neces-
sitated a visit to both the cardiac and obstetric clinics which 
decreased service efficiency. A combined O-C clinic was esta-
blished in Tygerberg Hospital in August 2010 for the screening, 
evaluation, risk stratification and management of pregnant 
patients with suspected or established cardiac disease. The 
combined O-C clinic consists of a cardiologist performing 
detailed echocardiography and a team of obstetricians lead by 
a sub-specialist in maternal-fetal medicine. Patients screened at 
either primary, secondary or tertiary level are referred to the 
clinic if they are known to have a cardiac lesion or are suspected 
of having undiagnosed cardiac disease and are either pregnant 
or are planning pregnancy. 
The purpose of this review is to describe the patient profile of 
this clinic and to share the lessons learnt from establishing 
the clinic.
MATERIALS AND METHODS
This retrospective review of records was performed at 
Tygerberg Academic Hospital, a secondary and tertiary level 
referral centre in the Western Cape Province of South Africa. 
The study population consisted of all women with known or 
suspected cardiac conditions in pregnancy that were evaluated 
and/or managed at the O-C clinic. Patients not known to the 
O-C clinic who were admitted to the labour ward on an 
emergency basis were not included in this study. 
Data was collected from the clinic records and patient files by 
the principal investigator. Women evaluated at the O-C clinic 
underwent a thorough antenatal and obstetric review by a 
consultant and resident obstetrician. Thereafter they under-
went meticulous cardiovascular and echocardiographic evalua-
tion by a dedicated cardiologist. Following these steps, com-
prehensive antenatal care, including the anticipated delivery 
plan, was formulated. During this process all women were 
assigned a risk estimation according to the modified World 
Health Organisation (WHO) classification of maternal cardio-
vascular risk(10) as well as the CARPREG score(11) as documented 
by Sui, et al. Women who were deemed at an exceptionally 
high risk of adverse cardiac events during pregnancy i.e. those 
with WHO class III-IV or a CARPREG score of >1 were 
managed throughout their pregnancy by this specialist clinic/
team including peripartum planning. Patients not meeting 
these criteria were referred back to their appropriate obstetric 
clinics with specific instructions for antenatal care and delivery.
The study was approved and registered by the Human Research 
and Ethics Committee of the University of Stellenbosch.
RESULTS
A total of 231 patients were evaluated at the O-C clinic from 
10 August 2010 - 4 December 2012. The documented under-
lying cardiac diseases and maternal characteristics are depicted 
in Table I. The most common reason for “screening” at the 
primary assessment was for previously managed or suspected 
RHD in 15 of the 27 visits. 
The numbers of first and subsequent follow-up visits per-
formed at the O-C clinic are depicted in Figure 1. Furthermore, 
women classified as WHO Class III-IV or with a CARPREG 
score of >1, whose pregnancies were managed entirely by 
the O-C clinic, are indicated in this figure. The breakdown of 
the pathology profile of these specific women is shown in 
Figure 2.
Medical conditions that warranted continuous care at the O-C 
clinic consisted of a single case of hypertrophic cardiomyo-
pathy, aortic aneurysm, aortic coarctation, 4 cases of ischaemic 
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FIGURE 1: Obstetric-Cardiac Clinic visits.
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heart disease, 2 cases of primary pulmonary hypertension and 
2 cases of severe restrictive lung disease with pulmonary hyper-
tension. A single case of cardiac arrhythmia was documented. 
This patient had persistent atrial fibrillation with no discernible 
cause. Nine patients with previous peripartum cardiomyo-
pathy were evaluated. Four of these women booked late 
(>24weeks gestation). During their initial evaluation 3 were 
asymptomatic and had a normal echocardiography evaluation 
(with left ventricular ejection fraction of >60%) while 2 women 
had not fully recovered, retaining severe left ventricular (LV) 
dysfunction on echocardiography (left ventricular ejection 
fraction of <35%).
The most common structural heart disease encountered in 
the clinic was rheumatic heart disease (RHD), accounting for 
79 (34.2%) of the women. The specific breakdown of the val-
vular heart disease encountered in these women is depicted 
in Figure 3. Mitral regurgitation (34.2%), mixed mitral valve 
disease (24.1%) and mitral stenosis (11.4%) were the most 
common RHD abnormalities. Furthermore 12.7% of the RHD 
women had already had a mitral valve – and 6.3% an aortic 
valve replacement.
Congenital heart disease accounted for 78 of the women 
seen at the clinic (33.8% of all first evaluations). The specific 
numbers of the underlying congenital heart disease are depicted 
in Figure 4. The most common pathology was ventricular septal 
defect (VSD) of which 10 (53%) had previous surgical repair; 
6 (31.6%) had no previous surgery and only a residual restrictive 
defect whereas 3 (15.8%) had no surgery without any evidence 
of a residual VSD on echocardiography.
DISCUSSION
The emphasis of this moderately sized retrospective study, that 
included all women seen from the inception of a dedicated 
O-C clinic, was to describe the patient profile of such an O-C 
clinic in a South African tertiary hospital. The most significant 
finding of this study is the apparent transition from the disease 
MANAGEMENT OF CARDIAC DISEASE IN PREGNANCY
TABLE 1: Epidemiological transition
#Median (Range), CHD: congenital heart disease, RHD: rheumatic heart disease. 
Prev PCMO: previous peripartum cardiomyopathy.
 2010 2011 2012 All
Total new visits 34 86 111 231
Age in years# 25 (18-39) 26 (16-44) 27 (16-47) 
<18 years (n) 0 4 5 9
>35 years (n) 3 13 23 39
Gravidity# 1 (1-5) 2 (1-6) 3 (1-6) -
Parity# 0 (0-4) 1 (0-5) 1 (0-4) -
Gestational age# 25 (11-38) 24 (7-39) 24 (6-38) -
(at clinic evaluation) 
<24w (n) 15 29 49 93
Indication for assessment    
Screening (n %) 2 7 18 27 (11.7)
Medical (n %) 1 20 17 38 (16.4)
Prev PCMO 2 4 3 9 (3.9)
CHD (n %) 11 33 34 78 (33.8)
RHD (n %) 18 22 39 79 (34.2)
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profile of a typical developing country (high burden of rheu-
matic heart disease) towards the disease profile associated with 
a more developed country (high burden of congenital heart 
disease) seen in a dedicated O-C clinic in this South African 
tertiary hospital. Furthermore, the lessons learnt from estab-
lishing this clinic yielded some important principles for clini-
cians caring for pregnant patients with severe and complex 
cardiac disease.
Women with known cardiac conditions who desire children, 
should ideally be evaluated prior to pregnancy or before 
clinical changes precipitate acute events. This is not always 
achievable in a developing country, nonetheless, in this study 
40.3% presented before 24 weeks gestation. Pregnant women 
with cardiac lesions need early and thorough evaluation in 
order to formulate a plan to optimise the outcomes for both 
the mother and her baby. Prior to August 2010, no formal O-C 
clinic existed at Tygerberg Academic Hospital and complex 
cases were evaluated by a cardiologist on an ad-hoc basis. 
After the O-C clinic had been formally established, the criteria 
for evaluation and admission to this clinic needed to be clari-
fied. While the criteria for evaluation were necessarily broad, 
only a select group of women with complex cardiac pathology 
could be continuously accommodated within the clinic due to 
capacity constraints. The criteria chosen were in line with 
the modified WHO risk classification(10) and the CARPREG(11) 
as well as the subsequent ZAHARA studies(12) for describing 
risk scores and predictive factors. 
This moderately sized retrospective evaluation over a 28 
month period revealed that RHD (34.2%), CHD (33.8%) and 
medical conditions including previous PCMO (20.3%) con-
stituted the vast majority of cases evaluated in the clinic. Of 
these patients 82 (35.5%) were retained for continued follow 
up in the O-C clinic. The disease profile of patients kept in 
the clinic was similar to those referred for evaluation. Several 
small retrospective reports and descriptive series from devel-
oping countries exist.(13-16) As would be expected in developing 
countries, all of these studies show a predominant RHD 
profile, constituting 65% - 90% of their pregnant cardiac 
cases. A more recent retrospective review, similar in size to this 
study, in an urbanised community still noted that RHD 
accounted for 63.5% while CHD accounted for less than 10% 
of cases.(17) The RHD:CHD ratio in the patients assessed at 
our clinic study still reflected the dominance of RHD, although 
to a lesser extent.
Pregnancies in asymptomatic patients with regurgitant valve 
lesions and preserved ventricular function are typically uncom-
plicated. This is in contrast to stenotic lesions, which are 
associated with a limited ability to adapt to the haemodynamic 
changes related to pregnancy. Mitral stenosis (MS) represents 
the most common and problematic valve lesion in developing 
countries. In this study MS of any severity comprised 35 of 
the 79 RHD patients (44.3%). This lesion is associated with a 
high fetal and maternal mortality as documented in a series 
from South Africa.(18) Furthermore, Silversides, et al., docu-
mented that in pregnant patients with moderate or severe 
mitral stenosis (mitral valve areas <1.5cm2), 67% developed 
a maternal cardiac event and 44% of infants were born 
prematurely or died (25%).(19) In contrast, mild mitral stenosis 
FIGURE 3: Rheumatic heart disease.
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rarely results in cardiac events. This further emphasises the 
need for early and meticulous assessment of these women 
in pregnancy.
In women of childbearing-age, aortic stenosis is a rare condi-
tion.(16,20) The data reported here supports this with only 
2 cases of aortic stenosis and 4 patients seen with aortic valve 
replacement due to RHD. The presence of a prosthetic heart 
valve places patients in a high risk category (WHO III) and 
constitute an important group requiring follow up at a spe-
cialist clinic. The anticoagulant management of these women 
has been a topic of substantial debate over recent times and 
requires meticulous care.(21,22)
In developed countries degenerative and congenital disorders 
predominate over rheumatic heart disease. Until the latter half 
of the twentieth century, women with congenital heart disease 
often died during pregnancy or before reaching reproductive 
age. Improved techniques of surgical repair have resulted in 
larger proportions of women with congenital heart disease 
achieving reproductive potential.(23,24) Recently the first results 
of the multicentre European study “Registry on Pregnancy 
and Cardiac disease” were published. This prospective study 
included 1 321 pregnancies from 28 countries. The study 
found CHD to be the most prevalent form of structural heart 
disease (66%).(25) This finding differs markedly from the pre-
viously mentioned studies from developing countries where 
the incidence ranged from 9% - 14%.(13-15) The incidence of 
CHD (33.8%) reported in this study is relatively high compared 
to other publications from developing countries but it is still 
similar to a study from India (36%).(16) The prominence of 
congenital heart disease in the pregnant population may be 
presumed to be a marker of the quality of socio-economic 
development and the health care system. However, this 
interpretation must be made with caution as the referral bias 
created by establishing a tertiary O-C clinic may have skewed 
the patient profile.
In a large prospective study from Roos-Hesselink, et al., the 
2 most frequent CHD lesions were septal defects and 
Tetralogy of Fallot (TOF).(25) The most frequent CHD lesions 
reported here were septal defects followed by mitral valve 
prolapse, pulmonary stenosis and TOF. Patients with TOF will 
almost always have undergone corrective surgery in infancy 
or childhood. These patients may still be afflicted by residual 
haemodynamic lesions of the right ventricular outflow tract 
in the shape of obstruction, regurgitation or both. Over time 
these haemodynamic effects cause pathophysiological changes 
including right ventricular hypertrophy, dilatation or dysfunc-
tion. However, Greutman, et al., found that most outcomes 
of pregnancies in patients with CHD and residual right ventri-
cular outflow tract lesions were good.(26)
Although the incidence of cardiac disease in pregnancy is 
reported to be stable, the clinical problems caused by these 
lesions are increasing.(27) The increasing numbers seen at the 
clinic in this study probably reflect better recruitment of 
appropriate cases (Figure 1).
The prevention of maternal deaths is an absolute priority as 
reflected by the Millennium Development Goal number 5.(28) 
The establishment of sub-specialist pregnancy clinics, such as 
the O-C clinic, are an important tool in preventing maternal 
and perinatal morbidity and mortality. For the patient with 
cardiac disease, planning of pregnancy and assessment early 
in pregnancy are important determinants of maternal health. 
Unfortunately, the local experience is that patients with cardiac 
disease presenting in pregnancy have often not been counselled 
before the pregnancy and/or present late in the pregnancy. 
Women of reproductive age attending cardiology clinics must 
be continually informed of the risks of unplanned pregnancies. 
Cardiologists conducting such clinics should employ the assis-
tance of family planning clinics, in this regard. The establish-
ment of the dedicated O-C clinic in Tygerberg Hospital has 
heightened awareness of the low rate of pre-pregnancy coun-
selling in the referring clinics. This deficiency is not addressed 
adequately by establishing a dedicated O-C clinic and greater 
awareness of the pre-pregnancy counselling of women with 
cardiac disease needs to be established at all levels of care. 
An equally important requirement at all levels of care is the 
ability to distinguish cardiac pathology from innocent murmurs 
during pregnancy. In the past the cardiac clinic in Tygerberg 
Hospital assessed a significant number of patients referred 
from obstetric clinics with innocent murmurs. The knowledge 
transfer that has occurred as a result of the dedicated O-C 
clinic has almost eliminated these referrals. Furthermore, the 
establishment of the O-C clinic has created an efficient system 
to ensure that pregnant patients with highly complex cardiac 
conditions have access to the required expertise on a continual 
basis. It is our assumption that the planning and outcome of 
pregnancies in these patients will be improved. However, this 
remains to be determined and the next critical step will be 
to evaluate the clinical outcomes of these women in order 
to determine the magnitude of “return” on the clinical 
“investment” required to establish and run such a clinic. This 
point will inform the objective of a planned follow-up study.
Potential shortcomings of this trial relate to the inherent short-
comings of a retrospective study based on registry/database 
type information. In the context of describing disease distribu-
tion in a clinic, referral bias is an important confounder that 
must be considered. Both referral patterns and disease charac-
teristics may play a role here. Referrals to the O-C clinic were 
taken from all medical service tiers be it primary, secondary or 
tertiary level. This addresses one aspect of referral bias based 
on referral pattern but others remain and of course complete 
control over referral to any clinic is limited. In terms of disease 
characteristics one could postulate that easily detectable lesions 
such as those leading to loud systolic murmurs, e.g. small VSDs 
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would preferentially be referred to the clinic and may there-
fore contribute to the relatively high disease burden of these 
lesions found. This potential confounder is mitigated in the 
index study by the fact that all patients followed up long term 
in the clinic and therefore included in the study, come from 
referrals of patients with known previous cardiac disease rather 
than from screening referrals. The screening referrals of cases 
with a suspicious murmer to the O-C clinic all screened nega-
tive for structural cardiac disease after a thorough work-up. The 
high clinic disease burden of, for example VSDs, therefore 
rather reflects the known high prevalence of these lesions in 
the paediatric service and this should be similar (using similar 
reasoning) for any lesion reported on in the index trial.
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